Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Endogenous Nitric Oxide
100%
Nitric Oxide Synthase Inhibitors
100%
Asymmetric Dimethylarginine
100%
Insulin Resistance
100%
Insulin Sensitivity
41%
Hypertension
25%
Cardiovascular Risk
16%
Insulin
16%
Endothelial Dysfunction
16%
Metabolic Syndrome
16%
Rosiglitazone
16%
Pharmacological Treatment
16%
Insulin Plasma
16%
Low-density Lipoprotein Cholesterol (LDL-C)
8%
Non-diabetic
8%
Glucose-insulin System
8%
Plasma Concentration
8%
Triglyceride Level
8%
Twice Daily
8%
Healthy Volunteers
8%
Plasma Parameters
8%
Fasting Triglycerides
8%
Low-density Lipoprotein Cholesterol Level
8%
Significant Relationship
8%
Reduced Sensitivity
8%
Triglyceride to High-density Lipoprotein Cholesterol Ratio
8%
Insulin Sensitizers
8%
Pharmacological Intervention
8%
Without Diabetes
8%
Glucose Disposal
8%
University Medical Centre
8%
Normal Blood Pressure
8%
Subject-independent
8%
Non-randomized Controlled Trial
8%
Insulin Suppression Test
8%
Biochemistry, Genetics and Molecular Biology
Nitric Oxide Synthase
100%
Blood Plasma
100%
Insulin Resistance
100%
Insulin Sensitivity
83%
Drug Therapy
33%
Rosiglitazone
33%
Low-Density Lipoprotein
16%
Blood Level
16%
Triglyceride
16%
HDL-Cholesterol
16%
Blood Pressure
16%
Normal Human
16%
Triacylglycerol Level
16%
Low Density Lipoprotein Cholesterol Level
16%
Cross Sectional Study
16%
Nursing and Health Professions
6 N,n' Dimethylarginine
100%
N(g),n(g) Dimethylarginine
100%
Insulin Resistance
100%
Nitric Oxide Synthase Inhibitor
100%
Drug Therapy
16%
Metabolic Syndrome X
16%
Endothelial Dysfunction
16%
Rosiglitazone
16%
High Density Lipoprotein Cholesterol
8%
Cardiovascular Disease
8%
University Hospital
8%
Cardiovascular Risk
8%
Blood Pressure
8%
Blood Level
8%
Triacylglycerol
8%
Low Density Lipoprotein Cholesterol
8%
Triacylglycerol Level
8%
Low Density Lipoprotein Cholesterol Level
8%
Volunteer
8%
Insulin Sensitizing Agent
8%
Cross-Sectional Study
8%
Pharmacology, Toxicology and Pharmaceutical Science
6 N,n' Dimethylarginine
100%
N(g),n(g) Dimethylarginine
100%
Nitric Oxide Synthase Inhibitor
100%
Insulin Resistance
100%
Low Density Lipoprotein Cholesterol
16%
Endothelial Dysfunction
16%
Triacylglycerol
16%
Metabolic Syndrome X
16%
Rosiglitazone
16%
Normal Human
8%
Cardiovascular Disease
8%
Cardiovascular Risk
8%
High Density Lipoprotein Cholesterol
8%
Insulin Sensitizing Agent
8%
Cross-Sectional Study
8%
Neuroscience
Nitric Oxide Synthase
100%
6 N,n' Dimethylarginine
100%
Blood Plasma
58%
Drug Therapy
16%
Triacylglycerol
16%
Rosiglitazone
16%
Low Density Lipoprotein Cholesterol
16%
High Density Lipoprotein Cholesterol
8%
Risk Factor
8%